USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersEfficient FrontierCorrelationsRisk/Return

US Market Open: Feb 9, 14:21 PM 2012

NYSE 8094.17 11.19 Index Moved Up

NASDAQ 2927.77 11.91 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for SLXP and PRGO...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Salix Pharmaceuticals Ltd. and

Perrigo Company

Volatility

Matrix

Run Correlation

Diversification

Very good diversification

Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and Perrigo Company in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

-0.21

Parameters

Time Period	1 Month [change]
Direction	Negative
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Suggest

48.9

Intraday

One Month

^(0.32)

0.65%

SLXP

NASDAQ

Salix Pharmaceuticals Ltd.

P/E	37.86	P/B Ratio	6.06
Open	49.47	Day Low	48.80
Market Cap	2.892B	Volume	147120
Last Close	49.22	Short Ratio	7.80
Last Traded	2/9/2012	Year High	50.28
Percent Change	0.65%	EBITDA	142.7M
Year Low	25.64	Absolute Change	0.32
Book Value	8.127	EPS	1.30
PEG Ratio	0.94	Day High	49.8084
Target Price	54.53	Current EPS	1.30
This Year EPS	2.55	Next Year EPS	2.79
Current PE	37.86	This Year PE	19.30
Next Year PE	17.64	Dividend	Not Applicable

Illumina's Board Unanimously Rejects Roche's Offer; Shire Announces FDA ...

BioMedReports (subscription) - Feb 8, 2012

By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on February 7, 2012.

2012-02-07

Salix Pharmaceuticals Announces FDA Granting of Priority Review Designation ...

MarketWatch (press release) - Feb 7, 2012

RALEIGH, NC, Feb 07, 2012 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. /quotes/zigman/87125/quotes/nls/slxp SLXP -0.25% today announced that the US Food and Drug Administration (FDA) has granted Priority Review designation for the Company's New Drug ...

Salix Pharmaceuticals Announces FDA Priority Review Designation for Crofelemer NDA
- NCTechNews (press release)

2012-02-07

Salix Pharmaceuticals Announces FDA Granting Of Priority Review Designation For Crofelemer NDA For Treatment Of Diarrhea

Reuters Key Development - Feb 7, 2012

2012-02-07

Salix Pharmaceuticals Crosses Above its 10-day MA (SLXP)

Financial News Network Online - Jan 31, 2012

Salix Pharmaceuticals (NASDAQ:SLXP) shares have crossed bullishly above their 10-day moving average of $46.89 on a volume of 132K shares.

2012-01-31

Salix Scores with Oral Relistor

2011-12-27

Salix Pharmaceuticals (SLXP): Zacks Rank Buy

2011-12-19

Zacks Bull and Bear of the Day Highlights: Salix Pharmaceuticals, Montpelier Re Holdings, Wal-Mart, Macy's and Best Buy

2011-11-28

94.0

Intraday

One Month

^0.06

0.06%

PRGO

NASDAQ

Perrigo Company

P/E	26.26	P/B Ratio	5.68
Open	94.21	Day Low	93.00
Market Cap	8.760B	Volume	576806
Last Close	93.945	Short Ratio	2.20
Last Traded	2/9/2012	Year High	104.70
Percent Change	0.06%	EBITDA	625.6M
Year Low	70.94	Absolute Change	0.06
Book Value	16.553	EPS	3.577
PEG Ratio	1.52	Day High	94.45
Target Price	105.21	Current EPS	3.577
This Year EPS	4.77	Next Year EPS	5.39
Current PE	26.26	This Year PE	19.69
Next Year PE	17.43	Dividend	0.29
Dividend Yield	0.31	Dividend Date	Mar 20

Perrigo Company To Present At The Leerink Swann 2012 Global Healthcare Conference

Daily Markets - Feb 8, 2012

ALLEGAN, Mich., Feb. 8, 2012 /PRNewswire/ - Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo CFO Judy Brown will present at the Leerink Swann 2012 Global Healthcare Conference on Wednesday, February 15th, at 2:30 PM (EST) at the Waldorf ...

2012-02-08

Perrigo Company to Present at the Leerink Swann 2012 Global Healthcare Conference

MarketWatch (press release) - Feb 8, 2012

ALLEGAN, Mich., Feb. 8, 2012 /PRNewswire via COMTEX/ -- Perrigo Company /quotes/zigman/77083/quotes/nls/prgo PRGO -1.38% today announced that Perrigo CFO Judy Brown will present at the Leerink Swann 2012 Global Healthcare Conference on Wednesday, ...

2012-02-08

Ultimate Market Recap: Wal-Mart Gets Healthier, Buffalo Wild Wings Up 15%

Wall St. Cheat Sheet - Feb 8, 2012

By Lindsey Grossman Late Monday, Greece announced plans to lay off 15000 public-sector workers by year's end according to The Wall Street Journal.

2012-02-07

Perrigo Pleases Bulls with Strong Earnings, Increased Guidance

Schaeffers Research - Feb 7, 2012

by Jim Cunningham (jcunningham@sir-inc.com) 2/7/2012 3:15:44 PM Perrigo Company (PRGO - 96.92) stepped into the earnings confessional before the opening bell this morning, and said its fiscal second-quarter profit increased 11% to $99.7 million, ...

2012-02-07

Perrigo Beats EPS, Top Line Solid

2012-02-07

Perrigo Files for Generic Astepro

2012-01-30

Perrigo Cleared for Generic Mucinex

2012-01-16